Fate Therapeutics Cash from Financing (TTM) Trends

Fate Therapeutics Inc (FATE)

3.865 -0.44 (-10.12%) USD | NASDAQ | Apr 25, 16:00

3.865 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	0.085M
September 30, 2023	1.782M
June 30, 2023	3.269M
March 31, 2023	6.617M
December 31, 2022	9.207M
September 30, 2022	11.11M
June 30, 2022	17.56M
March 31, 2022	17.88M
December 31, 2021	453.13M
September 30, 2021	454.62M
June 30, 2021	447.61M
March 31, 2021	719.44M
December 31, 2020	282.84M
September 30, 2020	264.20M
June 30, 2020	424.98M
March 31, 2020	150.12M
December 31, 2019	149.93M
September 30, 2019	165.56M
June 30, 2019	141.22M
March 31, 2019	141.68M
December 31, 2018	140.78M

Date	Value
September 30, 2018	182.12M
June 30, 2018	53.05M
March 31, 2018	49.88M
December 31, 2017	47.36M
September 30, 2017	57.20M
June 30, 2017	57.19M
March 31, 2017	57.29M
December 31, 2016	57.74M
September 30, 2016	3.754M
June 30, 2016	-5.066M
March 31, 2016	33.80M
December 31, 2015	35.60M
September 30, 2015	46.50M
June 30, 2015	56.26M
March 31, 2015	18.94M
December 31, 2014	18.37M
September 30, 2014	48.05M
June 30, 2014	58.00M
March 31, 2014	60.56M
December 31, 2013	60.56M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

0.085M

Minimum

Dec 2023

719.44M

Maximum

Mar 2021

195.85M

Average

149.93M

Median

Dec 2019

Cash from Financing (TTM) Benchmarks